Accelovance

Accelovance is a clinical CRO and market commercialization services company with offices in Beijing and Shanghai, China. Accelovance has developed a model to enhance the reliability and productivity of Phase I (outpatient) and Phase II-IV trials. Accelovance complements this offering with flexible CRO services tailored to meet sponsors' specific trial requirements.